PyInvesting

Market research

000520.KO Samil Pharmaceutical Co.,Ltd

KO KRW Healthcare

Latest close

6,870.00 —

As of Nov 19, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
159B
P/E ratio
Not available
Analyst target
10000
Dividend yield
Not available
Beta
0.32

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

Samil Pharmaceutical Co.,Ltd is currently in a long term downtrend where the price is trading 7.3% below its 200 day moving average.

From a valuation standpoint, the stock is 88.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.0.

Samil Pharmaceutical Co.,Ltd's total revenue sank by 0.4% to $30B since the same quarter in the previous year.

Its net income has increased by 42.4% to $-545M since the same quarter in the previous year.

Finally, its free cash flow fell by 146.9% to $-4B since the same quarter in the previous year.

Based on the above factors, Samil Pharmaceutical Co.,Ltd gets an overall score of 2/5.